TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
---|---|---|---|---|---|
2023 | Furmonertinib, a third-generation EGFR tyrosine kinase inhibitor, overcomes multidrug resistance through inhibiting ABCB1 and ABCG2 in cancer cells. | International Journal of Molecular Sciences | 5.6 | 37762275 | |
2023 | Exosomes Derived from Hypoxia-Cultured Human Adipose Stem Cells Alleviate Articular Chondrocyte Inflammaging and Post- Traumatic Osteoarthritis Progression | International Journal of Molecular Sciences | 5.6 | 37686220 | |
2018 | Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation | Cell Death Dis. | 5.6 | 30382081 | |
2021 | ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer | J Cell Physiol. | 5.546 | 33580514 | |
2021 | Overexpression of GLUT3 promotes metastasis of triple‐negative breast cancer by modulating the inflammatory tumor microenvironment | J Cell Physiol. | 5.546 | 33421130 | |
2021 | The second-generation PIM kinase inhibitor TP-3654 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drug. | Int J Mol Sci. | 5.542 | 34502348 | |
2021 | Overexpression of human ABCB1 and ABCG2 reduces the susceptibility of cancer cells to the histone deacetylase 6-specific inhibitor citarinostat. | Int J Mol Sci. | 5.542 | 33807514 | |
2021 | Structural basis of an epitope tagging system derived from Haloarcula marismortui bacteriorhodopsin I D94N and its monoclonal antibody GD-26 | FEBS J. | 5.542 | 34499806 | |
2019 | Promising therapeutic effect of thapsigargin nanoparticles on chronic kidney disease through the activation of Nrf2 and FoxO1 | Aging (Albany NY). | 5.515 | 31714893 |